Close relatives of people with multiple sclerosis (MS) are 100 times more likely to develop the neurological disorder than the general population, according to a new analysis of GEMS data. Among participants in GEMS, a large-scale observational study assessing MS risk among family members, about half said…
Discussion
It’s definitely dark and maybe even disturbing, but a book I have always enjoyed is Thomas Harris’ “The Silence of the Lambs.” If you’re unfamiliar with either the book or the movie, you’ve either been living a sheltered life or you need to find someone whose birth year starts with…
The National Multiple Sclerosis Society has designated UC Davis Health in California as a new Center for Comprehensive MS Care, recognizing its ability to provide coordinated, multidisciplinary care for people with multiple sclerosis (MS). The designation is part of the society’s Network of MS Healthcare Professionals, which…
Innocare Pharma has dosed the first healthy volunteer in a clinical trial in China testing ICP-538, its oral treatment candidate for multiple sclerosis (MS) and other autoimmune diseases. The novel experimental therapy works by promoting the degradation of the VAV1 protein, essential for the function of T-cells and…
People with multiple sclerosis (MS) who experience their first symptoms after age 50 tend to have faster disability progression than those with earlier disease onset, according to a recent study. The also more commonly develop primary progressive MS (PPMS). In addition, late-onset MS was associated with a higher risk of…
Get regular updates to your inbox.
